History has been just been made! The first-ever year-long CGM sensor was recently approved by the FDA. The Eversense 365 is an implantable CGM that’s cleared for use in people 18 years and older with type 1 or type 2 diabetes. It offers several unique benefits including on-body vibration alerts and a removable transmitter.
read more →
The Dexcom Stelo CGM was FDA-approved in March for adults with type 2 diabetes who are not on insulin, and it’s now available for purchase without a prescription. Stelo sends continuous blood sugar readings to a smartphone 24/7, revealing how food, exercise, and sleep can affect your blood glucose. It’s an empowering tool to help people with T2D better understand how glucose affects their health.
read more →
Do you know what the record is for the most CGM sensors launched in the same year by the same company? We don’t either, but Abbott is sure to be in the running. Their latest sensor – the FreeStyle Libre 3 Plus which can integrate with AID systems – is now available with a prescription.
read more →
As endocrinologists and people living with type 1 diabetes, Drs. E+P wanted to try Medtronic’s newest AID system after hearing about its new algorithm and SmartGuard feature. Dr. E shares his experience as a patient, and Dr. P offers his thoughts on the device from a provider’s point of view.
read more →
Many of us treat our phones like a fifth appendage, but now we can opt to leave our phones at home and still get CGM data. Dexcom recently announced that their G7 CGM can now connect directly to the Apple Watch for users in the U.S, offering people the freedom of real-time glucose readings even when their phone isn’t with them.
read more →
